Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Tissue Predictors of Abiraterone Benefit in Men With mCRPC

NCT03176381 is registered in ClinicalTrials.gov with Tianjin Medical University Second Hospital as lead sponsor.

NCT NCT03176381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03176381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Tissue Predictors of Abiraterone Benefit in Men With mCRPC
Lead sponsor
Tianjin Medical University Second Hospital
Phase
Observational
Overall status
Completed
Start date
May 5, 2017
Completion date
November 1, 2023
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic castration-resistant prostate cancer